MSB - a new dawn, page-1492

  1. 771 Posts.
    lightbulb Created with Sketch. 575
    Yes there are no institutions on the registry except Index funds ETF’s.
    The numbers will do the talking eventually but MSB past has taken it off the radar unfairly I might say.
    Biotech is a very hard sector to make money in as it requires allot of patience, money and things to go right. 99.9% fail as well.
    MSB is an extraordinary buy and we should be hovering up as many as we can while we can at these artificially low prices.
    I was an early investor in CSL on the government spin off and CSL was a whisker away of Administration and liquidation in its first few yrs then it accelerated and never looked back and remember CSL had a 10:1 split.
    I see MSB eclipsing CSL in market cap in 3 yrs.
    CSL was a nice change investment for me still I own today comfortably living off its low dividend but a high dividend to my initial investment.

    Not advice just my humble opinion
    Last edited by zilliqua: 03/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.65
Change
0.030(1.85%)
Mkt cap ! $2.108B
Open High Low Value Volume
$1.64 $1.67 $1.63 $4.884M 2.962M

Buyers (Bids)

No. Vol. Price($)
3 10583 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.66 16415 4
View Market Depth
Last trade - 16.12pm 27/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.